Growth hormone therapy for Prader–willi syndrome: challenges and solutions

Prader–Willi syndrome (PWS) is characterized by a dysregulation of growth hormone (GH)/insulin-like growth factor I axis, as the consequence of a complex hypothalamic involvement. PWS’ clinical picture seems to resemble the classic non-PWS GH deficiency (GHD), including short stature, excessive body...

Descripción completa

Detalles Bibliográficos
Autores principales: Grugni, Graziano, Sartorio, Alessandro, Crinò, Antonino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898426/
https://www.ncbi.nlm.nih.gov/pubmed/27330297
http://dx.doi.org/10.2147/TCRM.S70068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898426/
https://www.ncbi.nlm.nih.gov/pubmed/27330297
http://dx.doi.org/10.2147/TCRM.S70068

Ejemplares similares